(Q37967097)

26 August 2017

Regulatory T cells: banned cells for decades (English)

1 reference

26 August 2017

Stefan Beissert

2

1 reference

PubMed ID

22158548

26 August 2017

language of work or name

English

0 references

publication date

8 December 2011

1 reference

Journal of Investigative Dermatology

26 August 2017

1 reference

26 August 2017

132

1 reference

26 August 2017

3 Pt 2

1 reference

26 August 2017

864-871

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2011.375

26 August 2017

0 references

cites work

Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Regulatory T cells in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Low-dose, but not high-dose, cyclosporin A promotes regulatory T-cell induction, expansion, or both.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Natural regulatory T cells in infectious disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

https://api.crossref.org/works/10.1038%2FJID.2011.375

1 reference

7 January 2021

Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Phenotypical and functional specialization of FOXP3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

IL-35-mediated induction of a potent regulatory T cell population.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Foxp3+ regulatory T cells maintain immune homeostasis in the skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Epigenetic control of the foxp3 locus in regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

A function for interleukin 2 in Foxp3-expressing regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Interleukin 2 signaling is required for CD4(+) regulatory T cell function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Identification of regulatory T cells in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CTLA-4-Ig regulates tryptophan catabolism in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Expansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

FOXP3 promoter demethylation reveals the committed Treg population in humans.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

A two-step process for thymic regulatory T cell development.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Regulation of cutaneous immunity by the environment: an important role for UV irradiation and vitamin D.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Molecular orchestration of differentiation and function of regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

IL-2 family of cytokines in T regulatory cell development and homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Molecular mechanisms underlying FOXP3 induction in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Decrease of regulatory T cells in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Antigen-specific regulatory T cells--their induction and role in infection

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

T regulatory cells in atopic dermatitis and subversion of their activity by superantigens

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

DNA methylation controls Foxp3 gene expression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

ATP activates regulatory T Cells in vivo during contact hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Regulatory T cells: how do they suppress immune responses?

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Notch1 and TGFbeta1 cooperatively regulate Foxp3 expression and the maintenance of peripheral regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Mechanisms of foxp3+ T regulatory cell-mediated suppression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Control of intestinal inflammation by regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Immune regulation and control of regulatory T cells by OX40 and 4-1BB

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Glucocorticosteroids modify Langerhans cells to produce TGF-β and expand regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Activation requirements for the induction of CD4+CD25+ T cell suppressor function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Absence of T-regulatory cell expression and function in atopic dermatitis skin

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

How regulatory T cells work

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Interleukin-2 administration alters the CD4+FOXP3+ T-cell pool and tumor trafficking in patients with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

CCR6 regulates the migration of inflammatory and regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Nonredundant roles for Stat5a/b in directly regulating Foxp3

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Immunomodulatory drug FTY720 induces regulatory CD4(+)CD25(+) T cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FJID.2011.375

7 January 2021

Identifiers

DOI

10.1038/JID.2011.375

1 reference

26 August 2017

1 reference

PubMed ID

22158548